Genesys Biologics Private Limited

Develops biosimilars and fermentation-based products, with a focus on insulin biosimilars.

2014 | Hyderabad, Telangana (India) | Active
Last Updated:

Genesys Biologics Profile

Key Indicators

  • Authorised Capital ₹ 3.50 Cr
  • Paid Up Capital ₹ 2.33 Cr
  • Company Age 10 Year, 4 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 58.50 Cr
  • Satisfied Charges ₹ 61.28 Cr

About Genesys Biologics

Genesys Biologics Private Limited (GBPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 November 2014 and has a history of Ten years and four months. Its registered office is in Hyderabad, Telangana, India.

The Company is engaged in the Life Sciences Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.50 Cr and a paid-up capital of Rs 2.33 Cr.

The company currently has active open charges totaling ₹58.50 Cr. The company has closed loans amounting to ₹61.28 Cr, as per Ministry of Corporate Affairs (MCA) records.

Venkata Dasari, Tulasiramu Chatadi, Yelma Reddy, and Two other members serve as directors at the Company.

Company Details

  • Location

    Hyderabad, Telangana, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U24232TG2014PTC096432

  • Company No.

    096432

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    18 Nov 2014

  • Date of AGM

    28 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Hyderabad

Industry

Life Sciences

Who are the key members and board of directors at Genesys Biologics?

Board Members (5)

NameDesignationAppointment DateStatus
Venkata Dasari Country flag representing In Director 20-Aug-2015Current
Tulasiramu Chatadi Country flag representing In Director 20-Aug-2015Current
Yelma Reddy Country flag representing In Director 05-Feb-2015Current
Kondrella Roopesh Country flag representing Us Director 06-Feb-2015Current
Vamshider Rao Country flag representing In Director 18-Nov-2014Current

Financial Performance of Genesys Biologics.

Genesys Biologics Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Genesys Biologics revenue growth over time
Genesys Biologics profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
Revenue from Operations
Total Assets
Profit or Loss
Net Worth
EBITDA

What is the Ownership and Shareholding Structure of Genesys Biologics?

In 2023, Genesys Biologics had a public holding of 42.79%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹58.50 Cr

Satisfied Charges

₹61.28 Cr

Charges Breakdown by Lending Institutions

  • State Bank Of India : 58.50 Cr

Latest Charge Details

DateLenderAmountStatus
21 Jul 2017State Bank Of India₹58.50 CrOpen
03 Aug 2018State Bank Of India₹11.00 CrSatisfied
07 Sep 2017Others₹2.25 MSatisfied
02 Apr 2017State Bank Of India₹36.00 CrSatisfied
29 Oct 2016Others₹5.50 MSatisfied

How Many Employees Work at Genesys Biologics?

Genesys Biologics has a workforce of 259 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee growth trends for Genesys Biologics Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Genesys Biologics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genesys Biologics's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Genesys Biologics

Recent activity within the organization

  • Annual General Meeting

    Genesys Biologics Private Limited last Annual general meeting of members was held on 28 Sep 2024 as per latest MCA records.

  • Charges

    A charge registered on 03 Aug 2018 via Charge ID 100200402 with State Bank Of India was fully satisfied on 30 May 2024.

  • Balance Sheet

    Genesys Biologics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.

  • Charges

    A charge registered on 07 Sep 2017 via Charge ID 100203811 with Others was fully satisfied on 02 Dec 2023.

  • Charges

    A charge registered on 29 Oct 2016 via Charge ID 100203812 with Others was fully satisfied on 02 Dec 2023.

  • Charges

    A charge with State Bank Of India of Rs. 11.00 Cr registered on 03 Aug 2018 with Charge ID 100200402 was modified on 31 Mar 2023.

Frequently asked questions

  • What is the Incorporation or founding date of Genesys Biologics Private Limited?

    Genesys Biologics Private Limited was incorporated on 18 Nov 2014.

  • What is authorized share capital and paid-up capital of Genesys Biologics Private Limited?

    The authorized share capital of Genesys Biologics Private Limited is ₹ 3.50 Cr and paid-up capital is ₹ 2.33 Cr.

  • Who are the current board members & directors of Genesys Biologics Private Limited?

    Currently 5 directors are associated with Genesys Biologics Private Limited.

    • Venkata Krishna Rao Dasari
    • Tulasiramu Chatadi
    • Yelma Venkat Reddy
    • Kondrella Roopesh
    • Vamshider Joganpally Rao

  • What is the registered address of Genesys Biologics Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Genesys Biologics Private Limited is 6-3-248/1/1/A 4Th Floor Bhaskar Plaza Road No1, Banjara Hills India, Hyderabad, Telangana, 500034.

  • What is the corporate identification number (CIN) and company number of Genesys Biologics Private Limited?

    The corporate identification number (CIN) of Genesys Biologics Private Limited is U24232TG2014PTC096432 and the company number is 096432 as per Ministry of Corporate Affairs (MCA).

  • What is the official website of Genesys Biologics Private Limited?

    The Official website of Genesys Biologics Private Limited is https://www.genesysbiologics.com

  • How many employees does Genesys Biologics Private Limited currently have?

    As Per 2023 financial reports, 259 employees are currently employed by Genesys Biologics Private Limited.

  • What are the total open charges for Genesys Biologics Private Limited?

    As per the financial statements for fiscal Year 2023, The total open charges for Genesys Biologics Private Limited amount to ₹ 58.50 Cr.

  • When was the last Balance Sheet of Genesys Biologics Private Limited filed with the ROC?

    The most recent Balance Sheet for Genesys Biologics Private Limited was filed with the ROC on 31 Mar 2024.

People also Viewed